A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 371, Issue 15, Pages 1407-1417
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2014-10-09
DOI
10.1056/nejmoa1404588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparing DNA integration site clusters with scan statistics
- (2014) Charles C. Berry et al. BIOINFORMATICS
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Estimating abundances of retroviral insertion sites from DNA fragment length data
- (2012) Charles C. Berry et al. BIOINFORMATICS
- Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
- (2012) F. Candotti et al. BLOOD
- Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency
- (2012) J C M van der Loo et al. GENE THERAPY
- Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening
- (2011) L. Brown et al. BLOOD
- A method to sequence and quantify DNA integration for monitoring outcome in gene therapy
- (2011) Troy Brady et al. NUCLEIC ACIDS RESEARCH
- Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial
- (2010) G. P. Wang et al. BLOOD
- Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes
- (2010) Rebecca H. Buckley IMMUNOLOGIC RESEARCH
- Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better?
- (2010) Andrew R. Gennery et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
- (2010) Salima Hacein-Bey-Abina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chromatin Signatures in Multipotent Human Hematopoietic Stem Cells Indicate the Fate of Bivalent Genes during Differentiation
- (2009) Kairong Cui et al. Cell Stem Cell
- Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
- (2009) Alessandro Aiuti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
- (2008) Steven J. Howe et al. JOURNAL OF CLINICAL INVESTIGATION
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Self-inactivating Gammaretroviral Vectors for Gene Therapy of X-linked Severe Combined Immunodeficiency
- (2008) Susannah I Thornhill et al. MOLECULAR THERAPY
- Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors
- (2008) Daniela Zychlinski et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started